Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

One-step synthesis of 2-arylindoles from indolines via Pd-catalyzed oxidative dehydrogenation and C2-selective arylation

Yo-Sep Yanga, Jiyeon Yoob, Juhyeon Jeonb, Jun Hwi Baka, Jeong-Won Shinb, Hyuck-Jae Wonb, Hee Sung Hwanga, Ju Hee Kima, Jaehoon Sim*a and Nam-Jung Kim*ab
aDepartment of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. E-mail: kimnj@khu.ac.kr; jsim@khu.ac.kr
bDepartment of Biomedical and Pharmaceutical Sciences, Graduate School, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea

Received 30th June 2025 , Accepted 24th July 2025

First published on 7th August 2025


Abstract

We report an efficient synthetic approach to 2-arylindoles from indolines via a one-step process involving Pd-catalyzed oxidative dehydrogenation and a sequential C2-regioselective Heck-type reaction. The mild reaction conditions, which utilize O2 as the sole oxidant, show a broad substrate scope and good functional group compatibility.


2-Arylindoles are important structural motifs found in bioactive natural products and synthetic compounds, exhibiting a wide spectrum of pharmacological activities such as anticancer, antimicrobial, and antidiabetic properties (Scheme 1a).1 Owing to their ubiquitous application in medicinal chemistry, substantial efforts have been made to establish diverse synthetic methodologies for synthesizing 2-arylindoles.2 Among these, the regiospecific C–H arylation of indole is regarded as one of the most efficient methods for generating a diverse array of 2-arylindole derivatives.3 Recently, the application of innovative synthetic methods, such as direct C–H palladation and Pd-catalyzed Heck-type reactions, has enabled the C2-selective arylation of indoles without a directing group.4,5 To fully exploit the regioselective arylation of indoles for expanding reaction scope, the efficient preparation of multi-substituted indoles is essential, particularly given that most FDA-approved indole-derived drugs are di- or tri-substituted.6 However, the synthesis of such multi-substituted indole derivatives remains challenging, primarily because of the inherent electron-rich nature of the pyrrole ring in indole, especially at the N1 and C3 positions. Electrophilic aromatic substitution reactions, such as acylation, acrylation, halogenation, and nitration, are mainly used for the derivatization of indole, preferentially at the N1 and C3 positions, thereby hindering functionalization at the less reactive C4–C7 positions on the phenyl group.7 To address this limitation, indoline could be used as a surrogate for indole because its benzene ring possesses a higher electron density than that of indole. This approach successfully enables the synthesis of multi-substituted indoles but requires a two-step protocol, including an additional oxidation step. Recently, our group reported a breakthrough method for synthesizing indoles from N-free indolines via aerobic oxidation, using a minimal catalytic amount of Pd (Scheme 1b).8 Furthermore, our exploration of the indole scaffold has led to the development of a regioselective Pd(II)-catalyzed aerobic Heck-type reaction for the direct C2-arylation of N-free indoles (Scheme 1c).5 Inspired by our recent studies on indole chemistry and the challenges associated with accessing multi-substituted indoles, we developed an efficient one-step protocol for synthesizing 2-arylindoles directly from indolines (Scheme 1d).1b,9 To broaden the structural diversity and enhance functional group compatibility, the reaction was designed to proceed under mild conditions without stoichiometric use of acids, bases, or additives, employing molecular oxygen as the sole oxidant.
image file: d5ra04628a-s1.tif
Scheme 1 Representative examples of pharmacologically active 2-arylindoles and synthetic strategies to 2-arylindoles

To begin this study, 1H-indoline (1a) was chosen as the model substrate for reaction optimization (Table 1). Based on our previous reports,5,8 we initially evaluated ligand effects under the standard reaction conditions using phenylboronic acid (2a), 10 mol% Pd(OAc)2, and a ligand in DMF at 80 °C under an O2 atmosphere (entries 1–5). The use of neocuproine (L1) as the ligand facilitated the oxidative dehydrogenation step, affording indole (3a) in 71% yield and a small amount of the desired C2-aryl indole (4a) in 15% yield. In contrast, common bidentate ligands (L2–L5), although effective in promoting the dehydrogenation of indoline 1a, failed to control the regioselectivity of the subsequent arylation step, predominantly leading to the formation of the undesired C3-arylindole.

Table 1 Optimization of the reaction conditions

image file: d5ra04628a-u1.tif

Entrya Catalyst (10 mol%) Ligand (20 mol%) Solvent (0.3 M) T (°C) 3a b (%) 4a b (%) C3 b (%)
a All reactions were run on a 0.3 mmol scale with indoline 1a (1.0 equiv.), phenylboronic acid 2a (2.5 equiv.), Pd(II) catalyst (10 mol%), and neocuproine (20 mol%) in solvent (1.0 mL) at T °C under O2, 24 h.b Yields were determined by 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as the internal standard.c Additive DMF (1.0 equiv.) in entry 16.d Additive DMSO (1.0 equiv.) in entry 16.e The reaction was carried out for 48 h.f Isolated yield.
1 Pd(OAc)2 L1 DMF 80 71 15
2 Pd(OAc)2 L2 DMF 80 61 7
3 Pd(OAc)2 L3 DMF 80 41 34
4 Pd(OAc)2 L4 DMF 80 30 31
5 Pd(OAc)2 L5 DMF 80 35 33
6 Pd(OAc)2 L1 DMSO 80 51 7
7 Pd(OAc)2 L1 H2O 80 12 41
8 Pd(OAc)2 L1 DCE 80 28 53
9 Pd(OAc)2 L1 PhCl 80 14 73
10 Pd(OAc)2 L1 1,2-DCB 80 3 85
11c Pd(OAc)2 L1 1,2-DCB 40 14 60
12d Pd(OAc)2 L1 1,2-DCB 40 24 60
13 Pd(OAc)2 L1 1,2-DCB 100 24
14 Pd(OAc)2 L1 1,2-DCB 120 5
15 Pd(OAc)2 L1 1,2-DCB 60 87
16e Pd(OAc)2 L1 1,2-DCB 40 92(91)f


Subsequently, various solvents were screened (entries 6–10). This reaction showed a preference for halogenated benzene solvents over polar solvents, such as DMF, DMSO, H2O, and DCE. Among these, 1,2-dichlorobenzene (1,2-DCB) was identified as the optimal solvent, affording 4a in 85% yield. Based on previous reports indicating that the use of DMF and DMSO inhibits the oxidative Heck reaction,5,8 we hypothesized that the coordination of DMF or DMSO to the Pd(II) center may inhibit catalytic turnover. This hypothesis was supported by our observation that the addition of DMF or DMSO under the optimized conditions led to a decreased yield of 4a and incomplete conversion of indole 3a (entries 11 and 12).

Following solvent optimization, the effect of the reaction temperature was investigated. As the temperature increased, the reaction efficiency significantly decreased, accompanied by the formation of inactive Pd black. Notably, conducting the reaction at 40 °C with a prolonged reaction time provided the highest yield of 92% (entries 13–16). This relatively low reaction temperature was consistent with the mild conditions required for a broad substrate scope. Minor optimization of boronic acid loading and Pd(II) catalyst was also conducted to confirm the optimal conditions for Pd(OAc)2 (10 mol%), neocuproine (20 mol%), and aryl boronic acid (2.5 equiv.) in 1,2-DCB at 40 °C under an O2 atmosphere, as listed in entry 16 (ESI Table S1). A series of control experiments confirmed that all reaction components, including the Pd catalyst, ligand, oxygen, and reaction temperature, were essential for this reaction (ESI Table S2).

With the optimized conditions in hand, we examined the substrate scope of the indolines (Scheme 2). Indolines bearing methyl substituents at benzene core positions (4b–e) were smoothly converted into disubstituted indoles in moderate yields. Notably, the C4-methyl substituted indoline afforded the desired C2-arylindole 4b in relatively low yield, accompanied by the formation of a C3-arylated regioisomer. This result may be attributed to steric interactions among the C4-methyl group, neocuproine and the arylboronic acid, which likely hinder the Heck-type arylation step.5 Electron-rich alkoxy indolines (4f–h) readily underwent this transformation to afford the desired 2,5-disubstituted indoles in moderate yield. In contrast, electron-withdrawing indolines bearing halogen and ester substituents (4i–k) exhibited relatively lower reactivity. The dehydrogenation step might be initiated by substituting the indoline N–H with an electrophilic Pd(II) species. It is likely that the electron-withdrawing groups will decelerate this process, particularly at low temperatures, resulting in relatively poor conversion. Unlike other electron-withdrawing substituents and halogens, fluorine-substituted indoline (4l) exhibited relatively better reactivity, presumably due to the mesomeric effect of fluorine, which enhanced the nucleophilicity of the indoline nitrogen. Nevertheless, increasing the reaction temperature enabled moderate conversion of these substrates (4i–k). A gram-scale reaction performed under the optimized conditions afforded 4a in 86% yield, highlighting the feasibility of the protocol. To demonstrate the utility of our method in rapidly assembling biologically relevant multi-substituted indoles, we applied it to the synthesis of a known GPR40 agonist, 3-(2-phenyl-1H-indol-5-yl)propanoic acid (4m′).9 In general, the synthesis of 2,5-disubstituted indoles requires multistep procedures involving prefunctionalized intermediates prepared from aniline derivatives. The reported synthesis of the GPR40 agonist proceeds in seven steps. In contrast, the GPR40 agonist was efficiently synthesized in a four-step sequence using this strategy. The key intermediate (1m) was prepared by exploiting the inherent nucleophilic character of the C5 position in indoline.10 Our protocol successfully transformed 1m into the desired 2,5-disubstituted indole (4m) via sequential dehydrogenation and oxidative arylation. Final hydrolysis afforded the GPR40 agonist (4m′) in four steps.


image file: d5ra04628a-s2.tif
Scheme 2 Substrate scope of indolines. aAll reactions were run on a 0.3 mmol scale with indolines 1 (1.0 equiv.), arylboronic acid 2a (2.5 equiv.), Pd(OAc)2 (10 mol%), and neocuproine (20 mol%) in 1,2-DCB (1.0 mL) at 40 °C under O2, 48 h. bIsolated yield. cThe reaction was carried out at 80 °C for 24 h. dYield for the scaled-up experiment (3.0 mmol of 1a used).

Subsequently, the scope of phenylboronic acids was investigated to evaluate the generality of this protocol (Scheme 3). Electron-donating groups such as Me (4n and 4o), OMe (4p and 4q), and OH (4r), as well as electron-withdrawing groups including F (4s and 4t), Cl (4u), Br (4v), and CF3 (4w), were well tolerated, regardless of the substituent position (para or meta). Furthermore, ortho-methyl-containing 2-arylindole (4x) was obtained in a moderate yield. Notably, the base-labile ester (4y) and acid-labile Boc protecting group (4z) were compatible with this transformation, affording the corresponding products in moderate to good yields. This broad functional group tolerance is likely attributable to mild acid- and base-free conditions. We further evaluated the compatibility of aliphatic boronic acids, including methylboronic acid and cyclohexylboronic acid, under the optimized reaction conditions. However, the corresponding 2-alkylindole products were not detected. Only the simple indole was formed in moderate yield (ESI Table S3).


image file: d5ra04628a-s3.tif
Scheme 3 Substrate scope of arylboronic acids. aAll reactions were run on a 0.3 mmol scale with indoline 1a (1.0 equiv.), arylboronic acids 2 (2.5 equiv.), Pd(OAc)2 (10 mol%), and neocuproine (20 mol%) in 1,2-DCB (1.0 mL) at 40 °C under O2, 48 h. bIsolated yield. cThe reaction was carried out at 80 °C for 24 h.

To gain insight into the mechanism of this oxidative transformation, a series of mechanistic experiments were conducted. First, N-methyl indoline (1a′) failed to undergo the transformation under the optimized conditions, indicating that the oxidative dehydrogenation requires a free N–H moiety (Scheme 4a). To determine the initial step of the transformation, the reaction was performed under Ar using stoichiometric amounts of Pd(OAc)2 in the presence of indoline (1a) and phenylboronic acid (2a) (Scheme 4b). In this case, the dehydrogenated indole (3a) was obtained without the formation of a phenyl–phenyl dimer, which is typically generated via the transmetallation of phenylboronic acid 2a.11 These results suggest that the coordination of Pd(II) to the N–H of indoline occurs preferentially over transmetallation with boronic acid, indicating that the oxidative dehydrogenation of indoline precedes aryl transfer. Further kinetic analysis of the reaction revealed that 1H-indoline 1a was rapidly converted into indole 3a. After complete consumption of 1a, 3a was transformed into 2-arylindole (4a) (Scheme 4c). This confirms that the coordination between 1a and Pd(II) precedes the transmetallation with arylboronic acid (2a). Once 1a was depleted, the free Pd(II) catalyst underwent transmetallation to form a Pd–aryl species, enabling the desired C2-arylation of 3a.


image file: d5ra04628a-s4.tif
Scheme 4 Mechanistic investigation and supporting experiments. aReaction conditions: 1a or 1a′ (1.0 equiv.), 2a (2.5 equiv.), Pd(OAc)2 (10 mol%), neocuproine (20 mol%), and 1,2-DCB (1.0 mL) at 40 °C under O2, 48 h. bReaction conditions: 1a (1.0 equiv.), 2a (1.0 equiv.), Pd(OAc)2 (1.0 equiv.), neocuproine (2.0 equiv.), and 1,2-DCB (1.0 mL) at 40 °C under Ar, 48 h.

Based on the above mechanistic investigations and previous literature,5,8 we propose a plausible reaction mechanism, as depicted in Scheme 4d. The reaction is initiated by coordination of the free N–H of indoline (1a) to the Pd(II) catalyst (A), forming the complex B.8 Subsequent β-hydride elimination from B generates the imine intermediate C, which readily tautomerizes to the more stable indole 3a. The resulting Pd–H complex sequentially regenerates its initial state A via aerobic oxidation. Once indoline 1a is completely consumed, the neocuproine ligand facilitates transmetallation between phenylboronic acid and Pd(II) over electrophilic substitution with indole, leading to the formation of the Pd–aryl complex D in a nonpolar solvent.12,13 Subsequent Heck-type addition of the prepared indole 3a favors the formation of intermediate E-1 over E-2 influenced by the steric and electronic effects of the Pd–aryl complex D, as previously investigated.5 Finally, anti-β-hydride elimination produces the desired 2-arylindole 4a in a regioselective manner.

In conclusion, we developed an efficient one-step method to synthesize a variety of 2-arylindole derivatives from their corresponding indolines. The Pd(II)-catalyzed transformation integrates oxidative dehydrogenation and regioselective Heck-type arylation under mild acid- and base-free conditions. This protocol tolerates a broad range of functional groups and does not require high temperature or additives. Notably, our approach offers a straightforward synthetic strategy for accessing diverse multi-substituted 2-arylindoles via direct functionalization of the indoline scaffold. This method addresses a significant challenge in the fields of heterocyclic and medicinal chemistry and has the potential to broaden the chemical space of indole-based scaffolds.

Data availability

The data supporting this article have been included as part of the ESI and the additional data used and/or analysed during the current study are available from the corresponding author on reasonable request.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This work was supported by National Research Foundation (NRF) grants funded by the Korean government (NRF-2022R1A2C1009252, NRF-2021R1C1C1010044, and NRF-RS-2024-00399805), and by the BK21 FOUR Program of the Graduate School, Kyung Hee University (GS-1-JO-NON-20240398).

Notes and references

  1. (a) R. Gastpar, M. Goldbrunner, D. Marko and E. von Angerer, Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization, J. Med. Chem., 1998, 41, 4965–4972 CrossRef CAS PubMed; (b) S. Lal and T. J. Snape, 2-Arylindoles: a privileged molecular scaffold with potent, broad-ranging pharmacological activity, Curr. Med. Chem., 2012, 19, 4828–4837 CrossRef CAS; (c) R. Plummer, P. Lorigan, N. Steven, L. Scott, M. R. Middleton, R. H. Wilson, E. Mulligan, N. Curtin, D. Wang, R. Dewji, A. Abbattista, J. Gallo and H. Calvert, A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation, Cancer Chemother. Pharmacol., 2013, 71, 1191–1199 CrossRef CAS.
  2. (a) H. Song, Z. Y. Yang, C. H. Tung and W. G. Wang, Iron-Catalyzed Reductive Coupling of Nitroarenes with Olefins: Intermediate of Iron-Nitroso Complex, ACS Catal., 2020, 10, 276–281 CrossRef CAS; (b) C. Xu, V. K. Murugan and S. A. Pullarkat, Domino cyclization-alkylation protocol for the synthesis of 2,3-functionalized indoles from o-alkynylanilines and allylic alcohols, Org. Biomol. Chem., 2012, 10, 3875–3881 RSC; (c) H. C. Zhang, H. Ye, A. F. Moretto, K. K. Brumfield and B. E. Maryanoff, Facile solid-phase construction of indole derivatives based on a traceless, activating sulfonyl linker, Org. Lett., 2000, 2, 89–92 CrossRef CAS.
  3. (a) C. Sollert, K. Devaraj, A. Orthaber, P. J. Gates and L. T. Pilarski, Ru-Catalysed C–H Arylation of Indoles and Pyrroles with Boronic Acids: Scope and Mechanistic Studies, Chem.–Eur. J., 2015, 21, 5380–5386 CrossRef CAS PubMed; (b) V. K. Tiwari, N. Kamal and M. Kapur, Ruthenium-Catalyzed Heteroatom-Directed Regioselective C–H Arylation of Indoles Using a Removable Tether, Org. Lett., 2015, 17, 1766–1769 CrossRef CAS PubMed; (c) X. J. Zhu, J. H. Su, C. Du, Z. L. Wang, C. J. Ren, J. L. Niu and M. P. Song, Cobalt(II)-Catalyzed Oxidative C–H Arylation of Indoles and Boronic Acids, Org. Lett., 2017, 19, 596–599 CrossRef CAS PubMed.
  4. (a) N. R. Deprez, D. Kalyani, A. Krause and M. S. Sanford, Room temperature palladium-catalyzed 2-arylation of indoles, J. Am. Chem. Soc., 2006, 128, 4972–4973 CrossRef CAS; (b) B. S. Lane and D. Sames, Direct C–H bond arylation: selective palladium-catalyzed C2-arylation of N-substituted indoles, Org. Lett., 2004, 6, 2897–2900 CrossRef CAS PubMed; (c) N. Lebrasseur and I. Larrosa, Room temperature and phosphine free palladium catalyzed direct C-2 arylation of indoles, J. Am. Chem. Soc., 2008, 130, 2926–2927 CrossRef CAS PubMed; (d) S. D. Yang, C. L. Sun, Z. Fang, B. H. Li, Y. Z. Li and Z. J. Shi, Palladium-catalyzed direct arylation of (hetero)arenes with aryl boronic acids, Angew. Chem., Int. Ed., 2008, 47, 1473–1476 CrossRef CAS PubMed; (e) J. L. Zhao, Y. H. Zhang and K. Cheng, Palladium-catalyzed direct C-2 arylation of indoles with potassium aryltrifluoroborate salts, J. Org. Chem., 2008, 73, 7428–7431 CrossRef CAS.
  5. Y.-S. Yang, S. Lee, S. H. Son, H.-S. Yoo, Y. H. Jang, J.-W. Shin, H.-J. Won, J. Sim and N.-J. Kim, Ligand-controlled regiodivergent direct arylation of indoles oxidative boron Heck reaction, Org. Chem. Front., 2022, 9, 5906–5911 RSC.
  6. E. Vitaku, D. T. Smith and J. T. Njardarson, Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals, J. Med. Chem., 2014, 57, 10257–10274 CrossRef CAS PubMed.
  7. (a) H. S. Ma, T. Y. Yu, L. X. Chi, C. Huang, X. W. Li, R. Zhang and C. Deng, Recent advances in theoretical studies on transition-metal-catalyzed regioselective C–H functionalization of indoles, J. Mol. Model., 2022, 28, 287 CrossRef PubMed; (b) T. A. Shah, D. Bhusan, S. Pradhan and T. Punniyamurthy, Transition-metal-catalyzed site-selective C7-functionalization of indoles: advancement and future prospects, Chem. Commun., 2019, 55, 572–587 RSC; (c) K. Urbina, D. Tresp, K. Sipps and M. Szostak, Recent Advances in Metal-Catalyzed Functionalization of Indoles, Adv. Synth. Catal., 2021, 363, 2723–2739 CrossRef CAS.
  8. H.-S. Yoo, Y.-S. Yang, S. L. Kim, S. H. Son, Y. H. Jang, J.-W. Shin and N.-J. Kim, Syntheses of 1H-Indoles, Quinolines, and 6-Membered Aromatic N-Heterocycle-Fused Scaffolds via Palladium(II)-Catalyzed Aerobic Dehydrogenation under Alkoxide-Free Conditions, Chem.–Asian J., 2021, 16, 3469–3475 CrossRef CAS PubMed.
  9. (a) D. O. Yoon, X. Zhao, D. Son, J. T. Han, J. Yun, D. Shin and H. J. Park, SAR Studies of Indole-5-propanoic Acid Derivatives To Develop Novel GPR40 Agonists, ACS Med. Chem. Lett., 2017, 8, 1336–1340 CrossRef CAS PubMed; (b) X. D. Zhao, D. O. Yoon, J. Yoo and H. J. Park, Structure-Activity Relationship Study and Biological Evaluation of 2-(Disubstituted phenyl)-indole-5-propanoic Acid Derivatives as GPR40 Full Agonists, J. Med. Chem., 2021, 64, 4130–4149 CrossRef CAS.
  10. (a) W. L. Jia, N. Westerveld, K. M. Wong, T. Morsch, M. Hakkennes, K. Naksomboon and M. A. Fernández-Ibáñez, Selective C–H Olefination of Indolines (C5) and Tetrahydroquinolines (C6) by Pd/S,O-Ligand Catalysis, Org. Lett., 2019, 21, 9339–9342 CrossRef CAS PubMed; (b) K. Naksomboon, J. Poater, F. M. Bickelhaupt and M. A. Fernández-Ibáñez, Selective C-H Olefination of Aniline Derivatives via Pd/S,O-Ligand Catalysis, J. Am. Chem. Soc., 2019, 141, 6719–6725 CrossRef CAS.
  11. A. J. J. Lennox and G. C. Lloyd-Jones, Selection of boron reagents for Suzuki–Miyaura coupling, Chem. Soc. Rev., 2014, 43, 412–443 RSC.
  12. D. L. Bruns, D. G. Musaev and S. S. Stahl, Can Donor Ligands Make Pd(OAc)2 a Stronger Oxidant? Access to Elusive Palladium(II) Reduction Potentials and Effects of Ancillary Ligands via Palladium(II)/Hydroquinone Redox Equilibria, J. Am. Chem. Soc., 2020, 142, 19678–19688 CrossRef CAS PubMed.
  13. T. Diao, P. White, I. Guzei and S. S. Stahl, Characterization of DMSO Coordination to Palladium(II) in Solution and Insights into the Aerobic Oxidation Catalyst, Pd(DMSO)2(TFA)2, Inorg. Chem., 2012, 51, 11898–11909 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d5ra04628a

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.